Back to search

Spain· ES:72416

RALOXIFENO VIR 60 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

A raloxifene product containing raloxifeno, registered in Spain by Industria Quimica Y Farmaceutica Vir S.A.. The same ATC class is registered in 19 of our 19 countries.

ATC G03XC01

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedRALOXIFENO VIR 60 mg COMPRIMIDOS RECU…ATCG03XC01REGISTER NO.ES:72416PACKS LISTED1CHECKEDAugust 12, 2026

Where it is registered

Raloxifene is registered in 19 of 19 countries.

Countries holding a registration under ATC G03XC01 (raloxifene), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 11 of them publish a price we can compare per daily dose

Raloxifene · ATC G03XC01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of raloxifene costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.44 in France to $1.28 in Switzerland — a ×2.9 gap.

  • Spain: $0.84 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Raloxifene · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.28
  • ES Spain$0.84
  • IT Italy$0.70
  • FR France$0.44
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AEMPS CIMA (Spain)
Active substance
raloxifeno
Manufacturer
Industria Quimica Y Farmaceutica Vir S.A.
Country
Spain (ES)
ATC code
G03XC01
ATC class
Raloxifene
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
August 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    671118
    28
    EUR 20.64

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

183 interactions on record for raloxifene.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Raloxifene · interactions on record

183 records

  • 8 severe
  • 12 moderate
  • 6 minor
  • 157 info

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • BexaroteneL01XF03severe
  • CarfilzomibL01XG02severe
  • BexarotenL01XX25severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Raloxifene in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All raloxifene products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Raloxifen Stada
  • Cyprus · Ostiral
  • Germany · Raloxifen Al, Raloxifen-Hcl Hexal
  • France · Raloxifene Arrow, Raloxifene Biogaran
  • United Kingdom (Northern Ireland) · Evirex, Ostiral
  • Greece · Ostiral
  • Hungary · Clastellos, Raloxibone
  • Iceland · Evista, Optruma
  • Italy · Raloxifene Sandoz
  • Liechtenstein · Evista, Optruma
  • Netherlands · Raloxifeenhydrochloride Brillpharma, Raloxifene Hydrochloride Aurobindo
  • Norway · Evista, Optruma
  • Portugal · Raloxifeno Ciclum, Raloxifeno Exeltis
  • Romania · Raloxifen Arena
  • Sweden · Raloxifen Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aeb0afb4-38f7-48a4-b584-2b58d35ecb0c
GET /v1/drugs/aeb0afb4-38f7-48a4-b584-2b58d35ecb0c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1326409200000,\"rev\":1679572320000}",
  "nregistro": "72416",
  "substance": "raloxifeno"
}

See everything about raloxifene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.